Lupin developing a new HIV drug delivery system
TMCnet
TMC Launches New Sites ::  NGC  |  4GWE  |  Green Tech  |  Satellite  |  IT |  IVR |  ITEXPO SHOW NEWS  |  Healthcare  |  Cisco News  |  Skype News  |  Microsoft News  |  AVAYA News
  INDUSTRIES
  VERTICALS
  HORIZONTAL
  PUBLICATIONS
  FREE RESOURCES
  INTERNATIONAL
  EVENTS
  ABOUT TMC
  COMMUNITIES
TMCnet CHANNELS
#1 VoIP Enabler: Risk-free, Quick & Easy Deployment
3G, VoIP & IPTV Performance Management
Advanced Carrier Services
All-in-one IPPBX
Appliance Deployment
ATCA
Auto Dialer
Billing
BPA (3rd Party Remote Call Monitoring)
Business Automation
Business Phone Systems
Business VoIP
Call Center
Call Center Certification
Call Center Digital Signage
Call Center Furniture
Call Center Hiring
Call Center Management
Call Center On Demand
Call Center Outsourcing
Call Center Scheduling
Call Center Software
Call Center Solutions
Call Center Training
Call Center Workforce Management
Call Monitoring
Call Recording
Conference Call
Conference Phones
Conferencing
Contact Center Software
CRM Solutions
Dialer
DID/DDI
Digital Signage
e911
E911 Hosted Solutions
Ethernet Extender
Fax
Fax Over IP
HD Conference
Headsets
Hosted Call Center
Hosted Contact Center
Hosted PBX
Integrated Communications
IP Fax
IP Phone System
IP Phones
IVR
Lead Management Software
Master Agent
Mobile Management
Mobile Unified Communications
Mobile Video
NEBS
Open Source CRM
Phone Systems
Predictive Dialer
SIP
Speech Recognition and Text to Speech
Telecom Expense Management
Telecom Training
Telemarketing Software
Virtual Call Center
Virtual Office
Virtual PBX
Voice Broadcast
Voice Management
Voice Over IP
Voice Peering
Voicemail Replacement
VoIP Contact Center
VoIP Developer
VoIP Gateways
VoIP Monitoring
VoIP Robustness Testing
VoIP Test Solutions
VoIPSwitch
Web Conferencing
Web Meeting
Wholesale VoIP
Wireless Expense Management
Wireless Management
Workforce Management
Workforce Optimization
Share
TMCnews
[February 14, 2006]

Lupin developing a new HIV drug delivery system

(Ecomonic Times, The (India) (KRT) Via Thomson Dialog NewsEdge) Feb. 14--MUMBAI, India -- The Indian pharmaceutical industry's prowess in chemistry has not just enabled it to become the pillmaker to the world, it has also brought to the fore some innovative technologies to improve compliance among patients. One new product that is currently under development is a once-a-day anti-retroviral pill and has a potential to revolutionise HIV therapy.



Mumbai-based Lupin, the company that has developed this system, is in talks with the World Health Organisation (WHO) for the clinical development of the product. The new drug delivery system (NDDS) for anti-retroviral drugs used in the treatment of HIV has a combination of anti-retroviral drugs.

Lupin chairman, Dr DB Gupta, told ET: "This new platform is an innovation, which will bring down the number of tablets that the patient has to take." Currently, patients on anti-retrovirals have to take a number of pills. A combination of drugs is used to ensure that the virus does not develop resistance easily.



However, this means that the patient has to take too many pills through the day. Lupin's NDDS promises to bring it down to a single pill a day. "The product is currently undergoing clinical trials," Dr Gupta said. The trials are being conducted by the WHO and Lupin is providing the product for the clinical studies.

Once the product clears the trials, the WHO will start the initial marketing of the drug in 22 high burden countries, mostly in Africa and Asia. According to Dr Gupta, it should take less than a year for the product to become available in the market. However, though the new product will be more patient friendly, it is likely to be a little more expensive than the existing treatment protocol.

Lupin has patented the platform for this NDDS and does not expect any other player to launch a similar product. Other Indian companies like Ranbaxy, too, have developed products that have revolutionised treatment protocols. A few years ago, Ranbaxy developed a once-a-day ciprofloxacin. The product was licensed out to the innovator of ciprofloxacin -- Bayer.

[ Back To TMCnet.com's Homepage ]
Discussions:
Be the first to post a comment on this page!
 
By  
TMCnet
+ Add to the Discussion
Receive more news in your Email
Featured White Papers
Featured White Paper RSS feed
10 reasons to switch to an IP PBX
Satisfy Your Customers the First Time, Every Time
Application Whitelisting: A new security paradigm
view all white papers…
Top Stories
Today's TMCnet Top Stories and News Articles
Comcast's WiMax Bundle Challenges AT&T and Verizon: …
Plantronics Encourages Hawaiian Drivers to Use Hands-Free Devices Whil…
Gartner Positions Expand Networks in the 'Leaders' Quadrant
Insight Enterprises Earns MS 2009 Operational Excellence Award for Fif…
ACME, IdaTech to Deploy ElectraGen H2 for Indian Telecommunications Ma…
more of today's top stories...
Related VoIP News
Latest IP Communitions and VoIP News
Qwest Ethernet Services Selected by the State of Utah
J.D. Power and Associates Ranks Verizon Business Highest in Customer Satisfaction
Cadence GRE Technology Reduces Hitachi's PCB Design-Cycle Time
Coleman Technologies Offers Borderless Unified Cisco Network
Kyrgyzstan's National Telecom Operator Selects Cisco's Technologies

Today @ TMC
Upcoming Events
ITEXPO West 2009
 September 1-3, 2009
Los Angeles Convention Center
Los Angeles, CA
4G Wireless Evolution Conference
 Collocated with ITEXPO
September 1-3, 2009
Los Angeles Convention Center
Los Angeles, CA
view more…
Subscribe FREE to all of TMC's monthly magazines. Click here now.